Trademark: 87818646
Word
ATACC
Status
Dead
Status Code
602
Status Date
Thursday, January 17, 2019
Serial Number
87818646
Mark Type
5000
Filing Date
Friday, March 2, 2018
Abandoned Date
Monday, December 24, 2018

Trademark Owner History

Classifications
5 Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Biological preparations for the treatment of cancer; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Ferments for pharmaceutical purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Medical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Tumor suppressing agents; Clinical medical reagents; Anti-diabetic pharmaceuticals; Anti-cancer preparations; Cellular function activating agents for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
Color is not claimed as a feature of the mark.
The mark consists of the word ATACC in stylized letters.

Trademark Events
Jan 17, 2019
Abandonment Notice E-Mailed - Failure To Respond
Jan 17, 2019
Abandonment - Failure To Respond Or Late Response
Jun 21, 2018
Notification Of Non-Final Action E-Mailed
Jun 21, 2018
Non-Final Action E-Mailed
Jun 21, 2018
Non-Final Action Written
Jun 14, 2018
Assigned To Examiner
Mar 9, 2018
New Application Office Supplied Data Entered In Tram
Mar 6, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24